Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study.
AnnaLynn M WilliamsAngie Mae RoddayQinglin PeiTara O HendersonFrank G KellerAngela PunnettKara M KellySharon M CastellinoSusan K ParsonsPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
These data demonstrate successful collection of serial HRQoL from youth with high-risk pediatric HL and improvement in HRQoL over the course of initial therapy, sooner and to a greater extent in the group receiving the novel agent BV.